Matthew Barcus
Chardan Capital | Healthcare
Matthew Barcus is an analyst from Chardan Capital specializing in the Healthcare sector. They are beginning to establish their track record, with 1 stock rating so far. Their current stats show a success rate of 65.82% and an average return of 425.37%.
Matthew Barcus has only issued 1 rating so far. While the sample size is small, their early calls show a success rate of 65.82% and an average return of 425.37%. Investors may find their initial activity in the Healthcare sector worth watching as they build a track record.
#3
Out of 4773
1
Total Ratings
+65.82%
Success Rate
+425.37%
Average Return
Recent Ratings Analysis
Frequency Asked Questions
Who is Matthew Barcus?
Matthew Barcus is an analyst from Chardan Capital specializing in the Healthcare sector.
What is Matthew Barcus's success rate?
Matthew Barcus currently has a success rate of +65.82%.
How many ratings has Matthew Barcus issued?
Matthew Barcus has issued 1 stock ratings so far.
What is the average return of Matthew Barcus's calls?
Their stock ratings have generated an average return of +425.37%.
What is Matthew Barcus's ranking?
Matthew Barcus is ranked #3 out of 4773 analysts.
What types of ratings does Matthew Barcus give?
Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.
How can I follow Matthew Barcus?
You can follow Matthew Barcus by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.
What is the most recent rating by Matthew Barcus?
Their latest rating was a Buy on ZURA issued on 2025-03-26.